UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007076
Receipt number R000005707
Scientific Title Rituximab treatment for patients with Wegener's granulomatosis
Date of disclosure of the study information 2012/01/16
Last modified on 2015/01/22 14:55:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Rituximab treatment for patients with Wegener's granulomatosis

Acronym

Rituximab treatment for Wegener's granulomatosis

Scientific Title

Rituximab treatment for patients with Wegener's granulomatosis

Scientific Title:Acronym

Rituximab treatment for Wegener's granulomatosis

Region

Japan


Condition

Condition

Wegener's granulomatosis

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To study the efficacy and safety of rituximab for the treatment with Wegener's granulomatosis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

complete remission at 12 months

Key secondary outcomes

adverse events, BVAS/WG


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Weekly infusion of rituximab 500 mg for 4 times

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The case of Wegener's granulomatosis resistant to standard therapy with cyclophosphamide

Key exclusion criteria

The case who is disqualified by the physician

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshitaka Morita

Organization

Kawasaki Medical School

Division name

Department of Rheumatology

Zip code


Address

577 Matushima, Kurashiki, Okayama, Japan

TEL

086-462-1111

Email

rheumatology@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshitaka Morita

Organization

Kawasaki Medical School

Division name

Department of Rheumatology

Zip code


Address

577 Matushima, Kurashiki, Okayama, Japan

TEL

086-462-1111

Homepage URL


Email

morita@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

川崎医科大学附属病院(岡山県)


Other administrative information

Date of disclosure of the study information

2012 Year 01 Month 16 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2011 Year 01 Month 04 Day

Date of IRB


Anticipated trial start date

2011 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 01 Month 16 Day

Last modified on

2015 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005707


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name